Laqqan M, Hammadeh M E
Department of Obstetrics & Gynecology, Assisted Reproduction Laboratory, Saarland University, Homburg, Germany.
Andrologia. 2018 Apr;50(3). doi: 10.1111/and.12913. Epub 2017 Oct 26.
The purpose of this study was to evaluate the aberrations in sperm DNA methylation patterns of males suffering from reduced fecundity. A total of 108 males (65 males suffering from reduced fecundity as cases and 43 proven fertile males as a control) were included in the study. Thirty samples were subjected to 450K arrays as a screening phase, and then, three CpG sites located in the following genes: TYRO3, CGβ and FAM189A1 were selected to validate on 78 samples using deep bisulphite sequencing. A significant difference in the methylation level was found between cases and controls at all CpGs in TYRO3 gene-related amplicon (CpG1, p ≤ .003, CpG2, p ≤ .0001, CpG3, p ≤ .003 and CpG4, p ≤ .030) and CpG1 in CGβ gene-related amplicon (p ≤ .0001). Besides, a significant difference was found at two CpGs (CpG1, p ≤ .004 and CpG2, p ≤ .002) tested in the FAM189A1 gene-related amplicon. A significant correlation was found between the methylation level at CpG1 in the FAM189A1 gene and the different types of sperm motility. In conclusion, an alteration in the methylation levels of sperm DNA from males with reduced fecundity was showed. In addition, a relationship between variations in the methylation level of these CpGs and sperm motility has been observed.
本研究的目的是评估生育力下降男性精子DNA甲基化模式的异常。共有108名男性纳入本研究(65名生育力下降男性作为病例组,43名已证实有生育能力的男性作为对照组)。30个样本作为筛选阶段进行450K芯片检测,然后,选择位于以下基因TYRO3、CGβ和FAM189A1中的3个CpG位点,使用深度亚硫酸氢盐测序在78个样本上进行验证。在TYRO3基因相关扩增子的所有CpG位点(CpG1,p≤0.003;CpG2,p≤0.0001;CpG3,p≤0.003;CpG4,p≤0.030)以及CGβ基因相关扩增子的CpG1位点(p≤0.0001),病例组和对照组之间的甲基化水平存在显著差异。此外,在FAM189A1基因相关扩增子检测的2个CpG位点(CpG1,p≤0.004;CpG2,p≤0.002)也发现了显著差异。FAM189A1基因中CpG1位点的甲基化水平与不同类型的精子活力之间存在显著相关性。总之,生育力下降男性精子DNA的甲基化水平出现改变。此外,还观察到这些CpG位点甲基化水平的变化与精子活力之间存在关联。